Cofilin as a Promising Therapeutic Target for Ischemic and Hemorrhagic Stroke

Transl Stroke Res. 2016 Feb;7(1):33-41. doi: 10.1007/s12975-015-0438-2. Epub 2015 Dec 15.

Abstract

Neurovascular unit (NVU) is considered as a conceptual framework for investigating the mechanisms as well as developing therapeutic targets for ischemic and hemorrhagic stroke. From a molecular perspective, oxidative stress, excitotoxicity, inflammation, and disruption of the blood brain barrier are broad pathophysiological frameworks on the basis on which potential therapeutic candidates for ischemic and hemorrhagic stroke could be discussed. Cofilin is a potent actin-binding protein that severs and depolymerizes actin filaments in order to generate the dynamics of the actin cytoskeleton. Although studies of the molecular mechanisms of cofilin-induced reorganization of the actin cytoskeleton have been ongoing for decades, the multicellular functions of cofilin and its regulation in different molecular pathways are expanding beyond its primary role in actin cytoskeleton. This review focuses on the role of cofilin in oxidative stress, excitotoxicity, inflammation, and disruption of the blood brain barrier in the context of NVU as well as how and why cofilin could be studied further as a potential target for ischemic and hemorrhagic stroke.

Keywords: Cofilin; Intracranial hemorrhage; Ischemic stroke; Neurovascular unit.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Review

MeSH terms

  • Actin Depolymerizing Factors / drug effects
  • Actin Depolymerizing Factors / metabolism*
  • Animals
  • Brain Ischemia / drug therapy
  • Brain Ischemia / metabolism*
  • Humans
  • Intracranial Hemorrhages / drug therapy
  • Intracranial Hemorrhages / metabolism*
  • Stroke / drug therapy
  • Stroke / metabolism*

Substances

  • Actin Depolymerizing Factors